PT Brigit Biofarmaka Technologi Tbk (IDX:OBAT)

IDX:OBAT Revenue

PT Brigit Biofarmaka Technologi Tbk had revenue of 47.55B IDR in the quarter ending June 30, 2025, with 57.93% growth. This brings the company's revenue in the last twelve months to 142.43B, up 54.09% year-over-year. In the year 2024, PT Brigit Biofarmaka Technologi Tbk had annual revenue of 120.63B with 111.89% growth.

• Revenue (ttm): 142.43B
• Revenue Growth: +54.09%
• P/S Ratio: 1.82
• Revenue / Employee: 8.38B
• Employees: 23
• Market Cap: 259.20B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	120.63B	63.70B	111.89%
Dec 31, 2023	56.93B	18.43B	47.89%
Dec 31, 2022	38.50B	642.48M	1.70%
Dec 31, 2021	37.85B	-	-